These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8880057)

  • 1. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
    Weber C; Tam YK; Schmidtke-Schrezenmeier G; Jonkmann JH; van Brummelen P
    Eur J Clin Pharmacol; 1996; 51(1):87-90. PubMed ID: 8880057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers.
    Melia AT; Mulligan TE; Zhi J
    J Clin Pharmacol; 1996 Apr; 36(4):352-5. PubMed ID: 8728349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
    Piepho RW; Fendler KJ
    Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol.
    Fitzsimons TJ; Norris SC; Adam HK; Ryan J; McAinsh J
    Biopharm Drug Dispos; 1991; 12(1):81-94. PubMed ID: 2039814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
    Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
    Bevan EG; Pringle SD; Waller PC; Herrick AL; Findlay JG; Murray GD; Carmichael HA; Lorimer AR; Reid JL; Weir RJ
    J Hum Hypertens; 1993 Feb; 7(1):89-93. PubMed ID: 8450527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
    Dieterle W; Corynen S; Vaidyanathan S; Mann J
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):527-35. PubMed ID: 16300168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers.
    Zhi J; Moore R; Kanitra L; Mulligan TE
    J Clin Pharmacol; 2003 Apr; 43(4):428-35. PubMed ID: 12723464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients].
    Carré A
    Drugs; 1998; 56 Suppl 2():23-30. PubMed ID: 9813739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of vasodilators. Part I.
    Kirsten R; Nelson K; Kirsten D; Heintz B
    Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination.
    Marzo A; Monti NC; Dal Bo L; Mazzucchelli P; Crivelli F; Tettamanti RA; Ismaili S; Uhr MR; Ronchi C; Porziotta E
    Arzneimittelforschung; 2000 Sep; 50(9):802-8. PubMed ID: 11050696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antihypertensive agents: clinical pharmacology and therapeutic monitoring.
    White WB; Pandit RS
    Clin Lab Med; 1987 Sep; 7(3):607-23. PubMed ID: 2888562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL
    Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention.
    Foss OP; Graff-Iversen S; Istad H; Søyland E; Tjeldflaat L; Graving B
    Scand J Prim Health Care; 1999 Jun; 17(2):122-7. PubMed ID: 10439497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.